Cyto-Facto
Latest round
- Series B
Last raised
- Jun 2025
Total raised
- $16M
Investors
- 9
About Cyto-Facto
, operates as a gene cell preparations company it provides CMO/CDMO business, contract quality testing, and manufacturing consulting for gene cell preparations. In August 2023, Cyto-Facto Inc. The company offers contract manufacturing services for commercial gene and cell preparations (CMO business), process development for gene and cell preparations, as well as contract manufacturing services for clinical trial products (CDMO business). Additionally, they provide contract quality testing for gene and cell products, manufacturing services for gene and cell products, and consulting services. Additionally, they aim to diversify their business offerings by venturing into the virus vector sector.
Who invested in Cyto-Facto
9 investors across 2 rounds
See all investors in Cyto-Facto
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cyto-Facto
Who invested in Cyto-Facto?
Cyto-Facto has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cyto-Facto raised?
Cyto-Facto has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Cyto-Facto last raise money?
Cyto-Facto's most recent round on record is a Series B, in Jun 2025.
What does Cyto-Facto do?
, operates as a gene cell preparations company it provides CMO/CDMO business, contract quality testing, and manufacturing consulting for gene cell preparations.
Where is Cyto-Facto headquartered?
Cyto-Facto is headquartered in Kobe-shi, Japan.
Which VCs invest in companies like Cyto-Facto?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Cyto-Facto's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cyto-Facto? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.